125 related articles for article (PubMed ID: 22985925)
1. [Guidelines for high-quality use of biologic therapies in adults with plaque psoriasis].
Marques Pinto G; Filipe P
Acta Med Port; 2012; 25(2):125-41. PubMed ID: 22985925
[TBL] [Abstract][Full Text] [Related]
2. Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data.
Rustin MH
Br J Dermatol; 2012 Nov; 167 Suppl 3():3-11. PubMed ID: 23082810
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
Inzinger M; Heschl B; Weger W; Hofer A; Legat FJ; Gruber-Wackernagel A; Tilz H; Salmhofer W; Quehenberger F; Wolf P
Br J Dermatol; 2011 Sep; 165(3):640-5. PubMed ID: 21564068
[TBL] [Abstract][Full Text] [Related]
4. Cost per responder associated with biologic therapies for Crohn's disease, psoriasis, and rheumatoid arthritis.
Liu Y; Wu EQ; Bensimon AG; Fan CP; Bao Y; Ganguli A; Yang M; Cifaldi M; Mulani P
Adv Ther; 2012 Jul; 29(7):620-34. PubMed ID: 22843208
[TBL] [Abstract][Full Text] [Related]
5. [Psoriasis in the era of biologics].
Torres T; Velho GC; Sanches M; Selores M
Acta Med Port; 2010; 23(3):493-8. PubMed ID: 20654269
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
7. Could anti IL12/23 therapy replace anti-TNF biologics?
Ionescu MA; Lipozencić J
Acta Dermatovenerol Croat; 2009; 17(3):166-9. PubMed ID: 19818214
[TBL] [Abstract][Full Text] [Related]
8. [Future perspectives in the treatment of psoriasis: news in biological therapies].
Diamantino F; Ferreira A
Acta Med Port; 2011; 24(6):997-1004. PubMed ID: 22713194
[TBL] [Abstract][Full Text] [Related]
9. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
Tzu J; Kerdel F
Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
[TBL] [Abstract][Full Text] [Related]
10. Disease and treatment burden of psoriasis: examining the impact of biologics.
Raval K; Lofland JH; Waters H; Piech CT
J Drugs Dermatol; 2011 Feb; 10(2):189-96. PubMed ID: 21283925
[TBL] [Abstract][Full Text] [Related]
11. The role of topical therapy for patients with extensive psoriasis.
Feldman SR; Gelfand JM; Stein Gold L; Jones SD
Cutis; 2007 Jan; 79(1 Suppl 2):18-31. PubMed ID: 17367042
[TBL] [Abstract][Full Text] [Related]
12. Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents.
Sobell JM; Kalb RE; Weinberg JM
J Drugs Dermatol; 2009 Feb; 8(2):147-54. PubMed ID: 19213230
[TBL] [Abstract][Full Text] [Related]
13. Biologic therapies for psoriasis.
de Felice C; Ardigo M; Berardesca E
J Rheumatol Suppl; 2009 Aug; 83():62-4. PubMed ID: 19661545
[TBL] [Abstract][Full Text] [Related]
14. Is 'class effect' relevant when assessing the benefit/risk profile of a biologic agent?
Sterry W; van de Kerkhof P
J Eur Acad Dermatol Venereol; 2012 Aug; 26 Suppl 5():9-16. PubMed ID: 22758912
[TBL] [Abstract][Full Text] [Related]
15. S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.
Nast A; Boehncke WH; Mrowietz U; Ockenfels HM; Philipp S; Reich K; Rosenbach T; Sammain A; Schlaeger M; Sebastian M; Sterry W; Streit V; Augustin M; Erdmann R; Klaus J; Koza J; Muller S; Orzechowski HD; Rosumeck S; Schmid-Ott G; Weberschock T; Rzany B; ;
J Dtsch Dermatol Ges; 2012 Mar; 10 Suppl 2():S1-95. PubMed ID: 22386073
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
Puig L
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
Alwawi EA; Krulig E; Gordon KB
Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
[TBL] [Abstract][Full Text] [Related]
18. Implementing treatment goals for successful long-term management of psoriasis.
Mrowietz U
J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():12-20. PubMed ID: 22356631
[TBL] [Abstract][Full Text] [Related]
19. [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'].
Spuls PI; Tuut MK; van Everdingen JJ; de Rie MA;
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2121-5. PubMed ID: 15553355
[TBL] [Abstract][Full Text] [Related]
20. Infliximab for the treatment of adults with psoriasis.
Loveman E; Turner D; Hartwell D; Cooper K; Clegg A
Health Technol Assess; 2009 Jun; 13 Suppl 1():55-60. PubMed ID: 19567215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
